Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Spotlight

GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines

Business

Deals
Earnings
Manufacturing

Policy & Regulation

Regulatory Landscape
Drug Pricing
IP & Litigation

Tools & Trackers

What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings

Conference Coverage

Partner Insights

Generics Bulletin Perspectives

Exploring market-shifting topics for the off-patent sector.

Generics Bulletin

Medtech Insight

Mystery Surrounds Second Samsung Bioepis Avastin Biosimilar

Onbevzi Recommendation Follows Aybintio Approval In August

Nov 13 2020

• By Dean Rudge

Europe_Map_Connection — Avastin biosimilars are available in the EU • Source: Shutterstock

Related Content

Updated: Multiple Biosimilars To Avastin Have Launched In EU

Jul 24 2020

Samsung Bioepis Receives EU Bevacizumab Approval

Aug 21 2020

Centus Gets European Bevacizumab Approval

Sep 30 2020

Four adalimumabs compete in EU

Oct 26 2018

Related Companies

Samsung Bioepis Co., Ltd.

Additional Topics

Europe Biosimilars Regulation Cancer BioPharmaceutical

More from Biosimilars

More from Products

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Generics Top 50 Ranking
Biosimilars
Generics
Value Added Medicines

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window